ABSTRACT
China's pharmaceutical retailing market will be centralized by a large as a series of M&As will be launched by the nation's top pharmaceutical retail chains. In the meantime, the size of market will be expanded in 2008, as the nation will continue attaching more importance to explore the huge rural market. China's pharmaceutical chain industry will be shuffled in two or three years with some small-sized pharmaceutical retailers to be acquired by other big ones. Industry experts forecasted that pharmaceutical retail chains whose sales are expected to exceed CNY 2 billion would reach five to ten over the next three years. The industry has enjoyed a rapid growth, especially in some southern Chinese cities like Shenzhen, since 1995. However, blind development, severe local protectionism and improper internal management have hindered the industry's boom.
TABLE OF CONTENTS
PART I: Overview
Definition and Development of Chain Operation
1.1. Definition
1.1.1. Basic Definition
1.1.2. Franchising Mode
1.2. Advantages and Disadvantages
1.2.1. Characteristics
1.2.2. Advantages
1.3. Development of China's Chain Operation
1.3.1. Development Phases
1.3.2. Two Basic Modes
Status of China's Pharmaceutical Chain Industry
1.4. Status
1.4.1. Problems
1.4.2. 8 Characteristics
1.4.3. Development in 2007
1.5. Development of Pharmaceutical Chain Industry
1.5.1. Highlights
1.5.2. Difficulties
1.5.3. Method for Improvement
1.5.4. Rising Competitiveness
1.6. To Develop Pharmaceutical Chain Operation
1.6.1. Classification
1.6.2. Advantages
1.6.3. Problems
1.6.4. Method for Improvement
1.7. Tendency of Pharmaceutical Chain Operation
1.7.1. Tendency
1.7.2. Problems
1.7.3. Effect by Policy
1.8. Suggestions on China's Medicine Circulation System Reform
1.8.1. Guidelines
1.8.2. Goal
1.8.3. Policy and Measures
Status and Development Tendency of Pharmaceutical Industry
1.9. Operation of Pharmaceutical Industry in 2007
1.9.1. Top 10 Pharmaceutical Manufacturers in Terms of Sales in 2007
1.9.2. Analysis on Pharmaceutical Industry's Major Indexes in 2007
1.9.3. Development of Pharmaceutical Economy in 2007
1.10. 10 Phenomenon in China's Pharmaceutical Chain Industry
1.10.1. Separation of Hospitals and Pharmaceuticals
1.10.2. Off-shell Limited Selling
1.10.3. Leasing Counters
1.10.4. Drugstore Meeting
1.10.5. Stores Sell Medicines and Cosmetics
1.10.6. Transformation of Low-priced Medicine Supermarkets
1.10.7. Drugstore Union
1.10.8. Profit-making Mode
1.10.9. Drugstore Economy
1.10.10. Herbalist Doctors
1.11. Policy Environment of China's Pharmaceutical Industry in 2007
1.11.1. Measures Taken to Regulate Pharmaceutical Industry Began Working
1.11.2. Import and Export of China's Pharmaceutical Market in 2007
1.11.3. Pharmaceutical Reform Entered Key Stage in 2007
1.11.4. Major Competitors in China's Future Pharmaceutical Market
1.11.5. Accelerated Internationalization of Pharmaceutical Enterprises
1.11.6. Effect of 4 Policies on China's Pharmaceutical Industry in 2008
1.12. Forecast on China's Pharmaceutical Industry in 2008
1.12.1. To Boost Medical Security System Reform
1.12.2. New Characteristics
1.12.3. Restricted Factors
1.12.4. Forecast
1.12.5. Prospect of China's Raw Material Pharmaceutical Industry
1.12.6. Forecast on China's Pharmaceutical Industry in 2008-2011
1.13. Development Tendency of China's Pharmaceutical Industry in 2006-2010
1.13.1. Development Tendency
1.13.2. Major Participants and Competition
Market Demand of Pharmaceutical Consumption
1.14. Demand and Structure of Pharmaceutical Market
1.14.1. New Changes in Pharmaceutical Consumption Structure
1.14.2. Diversified Structure of Pharmaceutical Market
1.15. Consumption of Non-prescription Medicines
1.15.1. Consumers' Activity in Non-prescription Medicine Market
1.15.2. Soaring Demand for OTC Medicines in 2008-2020
1.16. Segmented Pharmaceutical Markets
1.16.1. Consumption of Cold Medicines
1.16.2. Consumption of Stomach Medicines
1.16.3. Anti-allergic Medicine Market and Market Size
PART II: Status
Pharmaceutical China Industry
1.17. Feasibility of Entering Pharmaceutical China Industry
1.17.1. Access Barriers
1.17.2. Status of Certified Apothecaries
1.17.3. GSP Certification
1.18. Informatization of Pharmaceutical Circulation
1.18.1. Traditional Management Mode Need Changes
1.18.2. Four Big Difficulties for Pharmaceutical Circulation Industry
1.18.3. Modern Concept
1.19. Status of Low-priced Medicine Supermarkets
1.19.1. Effect and Significance
1.19.2. Difficulties in Transformation
1.19.3. Development Bottleneck
1.19.4. Marketing Strategy
1.19.5. Transformation Tendency
Operating Mode of Pharmaceutical Chinas
1.20. Establishment of Core Competitiveness of Pharmaceutical Chinas
1.20.1. Definition of Core Competitiveness
1.20.2. Establishment of Core Competitiveness
1.20.3. Enhancing Core Competitiveness via Informatization
1.21. Changing Operating Mode of Pharmaceutical Chinas in 2007
1.21.1. Low Prices
1.21.2. High Gross Profit
1.21.3. OEM
1.21.4. Diversification
1.21.5. Drugstore Management
1.21.6. Human Resource Bottleneck
1.21.7. Direct Supply of Drugstores
1.21.8. Separation of Hospitals and Medicines
1.21.9. Community Medical Care Services
1.21.10. Capital Operation
1.22. Provincial-level Cooperation of Pharmaceutical Chinas
1.22.1. Misapprehension of Large-size
1.22.2. Competition and Cooperation
1.23. Cooperation Modes
1.23.1. Joint Venture
1.23.2. Procurement Union
1.23.3. Acquisition
1.23.4. Commercial-Commercial Union
1.23.5. Industrial-Commercial Union
PART III: Competition Pattern
Competition of in China's Regional Pharmaceutical Chains
1.24. Beijing
1.24.1. 24-hour Operating Mode Faced Quitting in 2007
1.24.2. Competition between Low-priced Drugstores and Community Hospitals in 2007
1.25. Shanghai
1.25.1. Commitment of Five Big Local Pharmaceutical Chains on Price
1.25.2. Operation of Economical Drugstores in 2007
1.26. Guangdong
1.26.1. Status of Guangdong's Pharmaceutical Retail Market
1.26.2. GSP Certification of Local Drugstores
1.26.3. Competition of Shenzhen's Pharmaceutical Retail Market
1.27. Competition of Pharmaceutical Chains in Other Cities
1.27.1. Haikou
1.27.2. Chengdu
1.27.3. Anhui
Major Pharmaceutical Retail Chains
1.28. Shenzhen Neptunus Bioengineering
1.28.1. Overview
1.28.2. Operation in 2007
1.28.3. Dynamics
1.29. Chongqing Tongjunge
1.29.1. Overview
1.29.2. Operation in 2007
1.29.3. Dynamics
1.30. Shenzhen Accord Pharmaceutical
1.30.1. Overview
1.30.2. Operation in 2007
1.30.3. Dynamics
1.31. Tianjin Zhongxin Pharmaceutical Group
1.31.1. Overview
1.31.2. Operation in 2007
1.31.3. Dynamics
1.32. Shanghai Pharmaceutical
1.32.1. Overview
1.32.2. Operation in 2007
1.32.3. Dynamics
1.33. Shanghai Fosun Industrial
1.33.1. Overview
1.33.2. Operation in 2007
1.33.3. Dynamics
1.34. Livzon Pharmaceutical Group
1.34.1. Overview
1.34.2. Operation in 2007
1.34.3. Dynamics
1.35. Harbin Pharmaceutical
1.35.1. Overview
1.35.2. Operation in 2007
1.35.3. Dynamics
1.36. Jiuzhitang
1.36.1. Overview
1.36.2. Operation in 2007
1.36.3. Dynamics
1.37. Beijing Tongrentang
1.37.1. Overview
1.37.2. Operation in 2007
1.37.3. Dynamics
Development of Large-sized Pharmaceutical Chains
1.38. Zhuzhou Qianjin Pharmaceutical
1.38.1. Overview
1.38.2. Operation in 2007
1.38.3. Dynamics
1.39. China Nepstar Chain Drugstore
1.39.1. Overview
1.39.2. Dynamics
1.40. Hunan Laobaixing Pharmacy China
1.40.1. Overview
1.40.2. Dynamics
1.41. Hubei Tongjitang Pharmacy
1.41.1. Overview
1.41.2. Dynamics
1.42. Beijing Golden Elephant Pharmacy Chain
1.42.1. Overview
1.42.2. Dynamics
1.43. Shenzhen Zhonglian Chain Drugstores
1.43.1. Overview
1.43.2. Dynamics
1.44. Hunan Jinsha Chain Drugstores
1.45. Yunan Yixintang Chain Store
1.46. Guangdong Bencao Medicine
1.47. Liaoning Chengda Fangyuan Pharmacy
PART IV: Operation and Management
Management of Chain Drugstores
1.48. Key of Management
1.48.1. Position Checking System
1.48.2. Structure of SSC
1.48.3. Introduce SSC to Chain Drugstores
1.49. Promotion Strategy of Chain Drugstores during Holidays
1.49.1. Medicine Supermarkets
1.49.2. Chain Drugstores
1.50. Positioning of Chain Drugstores
1.50.1. Improper Positioning
1.50.2. Analysis on Positioning
1.50.3. 3 Misapprehensions in Positioning
1.51. Chain Drugstores in Rural Areas
1.51.1. Capital Operation
1.51.2. Post Logistics
1.51.3. Chain Medicine Counter
1.51.4. From Urban Areas to Rural Places
Strategy for Operation of Chain Drugstores
1.52. Strategy for Development of China's Chain Drugstores
1.52.1. Integrated Marketing Strategy
1.52.2. Accelerate Expansion
1.52.3. Improve Services
1.52.4. Establish Industrial Union
1.53. Strategy for Operation
1.53.1. Operation Environment
1.53.2. Consumers' Demand
1.53.3. Major Competition Strategy
1.53.4. Operation with Brand Differentia
1.54. Operation and Competition of Chain Drugstores
1.54.1. Competitive Factors
1.54.2. Strategy for Retail
1.55. Profit-making Mode of China Nepstar Chain Drugstore
1.56. Consensus Policy of Chain Drugstores
1.56.1. Consensus Policy
1.56.2. Seeking Opportunity in Setting Consumers' Complaints
1.57. Successful Experience of US Pharmaceutical Chain Industry
1.57.1. Separation of Hospitals and Medicines
1.57.2. One-stop purchasing Mode
1.57.3. Rising Demand of Prescription Medicines
1.58. Successful Experience of Japan's Pharmaceutical Chain Industry
1.58.1. Characteristics of Japan's Pharmaceutical Chain Industry
1.58.2. Successful Operation Mode
1.59. Strategic Thinking on Informatization of Pharmaceutical Chains
1.59.1. General Thought
1.59.2. Relation between Management Mode and IT Planning
1.59.3. Demand for Informatization
1.59.4. General Planning
1.59.5. Application Architecture
PART V: Development Tendency and Investment
Development Tendency of Chain Drugstores
1.60. Diversification of Chain Drugstores
1.60.1. Diversification of Chain Drugstores in West Countries
1.60.2. Status of Diversification of Chain Drugstores in China
1.60.3. Problems Emerged in Diversification
1.60.4. Whether China's Chain Drugstores Need Diversification
1.60.5. How to Change Pitfalls into Opportunity
1.60.6. Choices for Diversification
1.61. Franchising: Development Tendency of Chain Drugstores
1.61.1. Basic Characteristics of Franchised Chain Drugstores
1.61.2. Franchising: Development Tendency of China's Chain Drugstores
1.61.3. Problem and Resolution
1.62. Increasing M&As
1.62.1. M&As in Global Pharmaceutical Chain Industry
1.62.2. New Round of M&As in Pharmaceutical Chain Industry
Analysis on Investing in Pharmaceutical Chain Industry
1.63. Potential of Hospital-Medicine Separation
1.63.1. Enduring Exploration
1.63.2. Business Opportunity
1.63.3. Rational Investment
1.64. Analysis on Rural Pharmaceutical Market
1.64.1. Huge Potential
1.64.2. Marketing
1.65. Investment and Operation of Pharmaceutical Chains
1.65.1. Market Prospect
1.65.2. Investment Opportunity
1.66. Strategy for Investing in Pharmaceutical Chain Industry in 2008
1.66.1. Analysis on Investment in 2007
1.66.2. Investment of Pharmaceutical Chain Industry Will Enter Golden Age
1.66.3. Prospect of Pharmaceutical Chain Industry in 2008
1.66.4. Strategy for Investment in 2008
TABLES:
Comparison between Traditional Operation and Franchised Operation
Comparison of Different Franchised Operation Modes
Distribution of Franchised Products
Franchised Operation Modes
Ranking of China's Chain Drugstores in Terms of Sales in 2007
Top 10 Pharmaceutical Manufacturers in Terms of Sales in February 2007
Top 10 Pharmaceutical Manufacturers in Terms of Sales in May 2007
Top 10 Pharmaceutical Manufacturers in Terms of Sales in August 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of China in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Beijing in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Tianjin in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Hebei in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Shanxi in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Inner Mongolia Autonomous Region in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Liaoning in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Jilin in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Heilongjiang in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Shanghai in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Jiangsu in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Zhejiang in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Anhui in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Fujian in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Jiangxi in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Shandongin Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Henan in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Hubei in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Hunan in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Guangdong in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Guangxi Autonomous Region in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Hainan in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Chongqing in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Sichuan in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Guizhou in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Yunnan in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Tibet Autonomous Region in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Shaanxi in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Gansu in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Qinghai in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Ningxia Autonomous Region in Jan-Aug 2007
Statistic of Major Economy Index of Pharmaceutical Manufacturing Industry of Xinjiang Autonomous Region in Jan-Aug 2007
Three Transformation Tendency of Low-priced Medicine Supermarkets
China's Supervision Policy on Pharmaceutical Industry in 2007
China's Pharmaceutical Enterprises That Listed in US in 2007
Profit and P/E Ratio of Pharmaceutical Industry in 2007-2008
Source of OTC Consumption Information
Rank of Stomach Medicines in Terms of Sales
Rank of Stomach Medicines in Terms of Sales Volume
Marketing Network of Shenzhen Neptunus Bioengineering
Forecast on Profit and Major Financial Indexes of Shenzhen Neptunus Bioengineering in 2005-2008
Major Affiliates of Shenzhen Neptunus Bioengineering
Major Subsidiaries of Shenzhen Neptunus Bioengineering
Profit of Shenzhen Neptunus Bioengineering's Major Subsidiaries in 2000-2005
Comparison of Some Listed Pharmaceutical Enterprises' P/E Ratio
Structure of Shenzhen Neptunus Bioengineering's Main Business in 2007 Q2
EPS Index of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Profitability of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Operating Ability of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Solvency of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Capital Structure of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Growth Ability of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Cash Flow of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Profit Distribution of Shenzhen Neptunus Bioengineering in 2007 Q1-Q3
Structure of Chongqing Tongjunge's Main Business in 2007 Q2
EPS Index of Chongqing Tongjunge in 2007 Q1-Q3
Profitability of Chongqing Tongjunge in 2007 Q1-Q3
Operating Ability of Chongqing Tongjunge in 2007 Q1-Q3
Solvency of Chongqing Tongjunge in 2007 Q1-Q3
Capital Structure of Chongqing Tongjunge in 2007 Q1-Q3
Growth Ability of Chongqing Tongjunge in 2007 Q1-Q3
Cash Flow of Chongqing Tongjunge in 2007 Q1-Q3
Profit Distribution of Chongqing Tongjunge in 2007 Q1-Q3
Structure of Shenzhen Accord Pharmaceutical's Main Business in 2007 Q2
EPS Index of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Profitability of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Operating Ability of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Solvency of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Capital Structure of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Growth Ability of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Cash Flow of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Profit Distribution of Shenzhen Accord Pharmaceutical in 2007 Q1-Q3
Structure of Sales Revenue of Main Business of Shenzhen Accord Pharmaceutical in 2006
Forecast on Main Business Sales Revenue Growth of Shenzhen Accord Pharmaceutical in 2003-2009
Motives of Shenzhen Accord Pharmaceutical's Main Business
Development of Shenzhen Accord Pharmaceutical in 2006-2007
Four Profit Growth Points of Shenzhen Accord Pharmaceutical's New Production Base
Sale Revenue and Forecast on Profit of Shenzhen Zhijun Pharmaceutical in 2005-2009
Change Tendency of Expenditures of Shenzhen Accord Pharmaceutical in 2004-2007
Sale Revenue and Forecast on Profit of Shenzhen Accord Pharmaceutical in 2005-2009
Sale Revenue and Forecast on Profit of Shenzhen Accord Pharmaceutical's Main Business in 2005-2009
Main Business Revenue of Shenzhen Accord Pharmaceutical in 2004-2009
Major Financial Indexes of Shenzhen Accord Pharmaceutical in 2006-2008
Forecast on Profit of Shenzhen Accord Pharmaceutical's Other Businesses in 2005-2009
Forecast on Profit of Shenzhen Accord Pharmaceutical in 2007-2009
Structure of Tianjin Zhongxin Pharmaceutical Group's Main Business in 2007 Q2
EPS Index of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Profitability of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Operating Ability of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Solvency of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Capital Structure of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Growth Ability of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Cash Flow of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Profit Distribution of Tianjin Zhongxin Pharmaceutical Group in 2007 Q1-Q3
Analysis and Forecast on Tianjin Zhongxin Pharmaceutical Group's Financing in 2006-2008
Major Financial Indexes of Tianjin Zhongxin Pharmaceutical Group in 2006-2009
Tianjin Zhongxin Pharmaceutical Group's Major Affiliates and Their Products
Tianjin Zhongxin Pharmaceutical Group's Other Products
Analysis on Profit of Tianjin Zhongxin Pharmaceutical in 2005-2009
Analysis on Cash Flow of Tianjin Zhongxin Pharmaceutical in 2006-2009
Profit Table of Tianjin Zhongxin Pharmaceutical in 2006-2009
Liabilities Table of Tianjin Zhongxin Pharmaceutical in 2006-2009
Structure of Shanghai Pharmaceutical's Main Business in 2007 Q2
EPS Index of Shanghai Pharmaceutical in 2007 Q1-Q3
Profitability of Shanghai Pharmaceutical in 2007 Q1-Q3
Operating Ability of Shanghai Pharmaceutical in 2007 Q1-Q3
Solvency of Shanghai Pharmaceutical in 2007 Q1-Q3
Capital Structure of Shanghai Pharmaceutical in 2007 Q1-Q3
Growth Ability of Shanghai Pharmaceutical in 2007 Q1-Q3
Cash Flow of Shanghai Pharmaceutical in 2007 Q1-Q3
Profit Distribution of Shanghai Pharmaceutical in 2007 Q1-Q3
Forecast on Shanghai Pharmaceutical's Financial Result s in 2006-2009
Forecast and Estimation of Shanghai Pharmaceutical in 2005-2009
Forecast on Profit of Shanghai Pharmaceutical in 2005-2009
Structure of Shanghai Fosun Industrial's Main Business in 2007 Q2
EPS Index of Shanghai Fosun Industrial in 2007 Q1-Q3
Profitability of Shanghai Fosun Industrial in 2007 Q1-Q3
Operating Ability of Shanghai Fosun Industrial in 2007 Q1-Q3
Solvency of Shanghai Fosun Industrial in 2007 Q1-Q3
Capital Structure of Shanghai Fosun Industrial in 2007 Q1-Q3
Growth Ability of Shanghai Fosun Industrial in 2007 Q1-Q3
Cash Flow of Shanghai Fosun Industrial in 2007 Q1-Q3
Profit Distribution of Shanghai Fosun Industrial in 2007 Q1-Q3
Marketing Network of Livzon Pharmaceutical Group
Structure of Livzon Pharmaceutical Group's Main Business in 2007 Q2
EPS Index of Livzon Pharmaceutical Group in 2007 Q1-Q3
Profitability of Livzon Pharmaceutical Group in 2007 Q1-Q3
Operating Ability of Livzon Pharmaceutical Group in 2007 Q1-Q3
Solvency of Shanghai Livzon Pharmaceutical Group in 2007 Q1-Q3
Capital Structure of Livzon Pharmaceutical Group in 2007 Q1-Q3
Growth Ability of Livzon Pharmaceutical Group in 2007 Q1-Q3
Cash Flow of Livzon Pharmaceutical Group in 2007 Q1-Q3
Profit Distribution of Livzon Pharmaceutical Group in 2007 Q1-Q3
Financial Data and Estimation of Livzon Pharmaceutical Group in 2005-2009
Profit Table of Livzon Pharmaceutical Group in 2005-2009
Assets Liabilities of Livzon Pharmaceutical Group in 2005-2009
Cash Flow of Livzon Pharmaceutical Group in 2005-2009
Financial Indexes of Livzon Pharmaceutical Group in 2005-2009
Profit and Estimation of Livzon Pharmaceutical Group in 2005-2009
Structure of Harbin Pharmaceutical's Main Business in 2007 Q2
EPS Index of Harbin Pharmaceutical in 2007 Q1-Q3
Profitability of Harbin Pharmaceutical in 2007 Q1-Q3
Operating Ability of Harbin Pharmaceutical in 2007 Q1-Q3
Solvency of Harbin Pharmaceutical in 2007 Q1-Q3
Capital Structure of Harbin Pharmaceutical in 2007 Q1-Q3
Growth Ability of Harbin Pharmaceutical in 2007 Q1-Q3
Cash Flow of Harbin Pharmaceutical in 2007 Q1-Q3
Profit Distribution of Harbin Pharmaceutical in 2007 Q1-Q3
Marketing Network of Jiuzhitang
Structure of Jiuzhitang's Main Business in 2007 Q2
EPS Index of Jiuzhitang in 2007 Q1-Q3
Profitability of Jiuzhitang in 2007 Q1-Q3
Operating Ability of Jiuzhitang in 2007 Q1-Q3
Solvency of Jiuzhitang in 2007 Q1-Q3
Capital Structure of Jiuzhitang in 2007 Q1-Q3
Growth Ability of Jiuzhitang in 2007 Q1-Q3
Cash Flow of Jiuzhitang in 2007 Q1-Q3
Profit Distribution of Jiuzhitang in 2007 Q1-Q3
Major Financial Indexes of Jiuzhitang in 2006-2009
Change of Jiuzhitang's Gross Profit in 2003-2007
Forecast on Jiuzhitang's Main Profit in 2005-2009
Assets Liabilities Table of Jiuzhitang in 2006-2009
Cash Flow Table of Jiuzhitang in 2006-2009
Profit Table of Jiuzhitang in 2006-2009
Major Financial Ratio of Jiuzhitang in 2006-2009
Structure of Beijing Tongrentang's Main Business in 2007 Q2
EPS Index of Beijing Tongrentang in 2007 Q1-Q3
Profitability of Beijing Tongrentang in 2007 Q1-Q3
Operating Ability of Beijing Tongrentang in 2007 Q1-Q3
Solvency of Beijing Tongrentang in 2007 Q1-Q3
Capital Structure of Beijing Tongrentang in 2007 Q1-Q3
Growth Ability of Beijing Tongrentang in 2007 Q1-Q3
Cash Flow of Beijing Tongrentang in 2007 Q1-Q3
Profit Distribution of Beijing Tongrentang in 2007 Q1-Q3
Forecast on Profit of Beijing Tongrentang in 2006-2009
Major Financial Indexes of Beijing Tongrentang in 2006-2008
Financial Digest of Beijing Tongrentang in 2006-2009
Profit Margin and Estimation of Beijing Tongrentang in 2006-2009
Structure of Zhuzhou Qianjin Pharmaceutical's Main Business in 2007 Q2
EPS Index of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Profitability of Zhuzhou Qianjin Pharmaceutical g in 2007 Q1-Q3
Operating Ability of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Solvency of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Capital Structure of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Growth Ability of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Cash Flow of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Profit Distribution of Zhuzhou Qianjin Pharmaceutical in 2007 Q1-Q3
Forecast on Profit of Zhuzhou Qianjin Pharmaceutical in 2005-2009
Forecast on Main Business of Zhuzhou Qianjin Pharmaceutical in 2007-2009
Profit-Loss Account of Zhuzhou Qianjin Pharmaceutical in 2005-2009
Theme and Product Mix of Holiday Promotion
Retail Channel I of Chain Drugstores
Retail Channel II of Chain Drugstores
Product Structure of Japanese Chain Drugstores
